Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Gains from Sales and Divestitures (2022 - 2024)

OneMedNet (ONMD) has disclosed Gains from Sales and Divestitures for 2 consecutive years, with $200000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Gains from Sales and Divestitures fell 24.79% to $200000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $200000.0, a 24.79% decrease, with the full-year FY2024 number at $200000.0, down 24.79% from a year prior.
  • Gains from Sales and Divestitures was $200000.0 for Q4 2024 at OneMedNet, down from $265914.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $265914.0 in Q4 2023 to a low of $200000.0 in Q4 2024.